Zijun Wang
139 Renmin Road
Changsha, 410011, China
Changsha, 410011, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
2D4, a humanized monoclonal antibody targeting CD132, is a promising treatment for systemic lupus erythematosus.
Journal: Signal transduction and targeted therapy
Published: November 24, 2023
Microbiome dynamics in rheumatic diseases.
Journal: Current opinion in rheumatology
Published: November 17, 2023
Comprehensive Analysis of Aberrantly Expressed Competitive Endogenous RNA Network and Identification of Prognostic Biomarkers in Pheochromocytoma and Paraganglioma.
Journal: OncoTargets and therapy
Published: July 15, 2020
UBASH3B Is a Novel Prognostic Biomarker and Correlated With Immune Infiltrates in Prostate Cancer.
Journal: Frontiers in oncology
Published: May 13, 2019
T cell receptor β repertoires as novel diagnostic markers for systemic lupus erythematosus and rheumatoid arthritis.
Journal: Annals of the rheumatic diseases
Published: March 28, 2019
E4BP4-mediated inhibition of T follicular helper cell differentiation is compromised in autoimmune diseases.
Journal: The Journal of clinical investigation
Published: March 22, 2019
Mechanistic insights into Nav1.7-dependent regulation of rat prostate cancer cell invasiveness revealed by toxin probes and proteomic analysis.
Journal: The FEBS journal
Published: June 19, 2018
Crosstalk between metabolism and epigenetic modifications in autoimmune diseases: a comprehensive overview.
Journal: Cellular and molecular life sciences : CMLS
Published: December 25, 2017
MicroRNA-210 overexpression promotes psoriasis-like inflammation by inducing Th1 and Th17 cell differentiation.
Journal: The Journal of clinical investigation
Published: September 12, 2017
IL-6/STAT3 pathway induced deficiency of RFX1 contributes to Th17-dependent autoimmune diseases via epigenetic regulation.
Journal: Nature communications
Published: August 02, 2017
Last Updated: 09/26/2026